Archive: 01/08/2018
Researchers find treatment for ultra-rare disease
A new study published in Molecular Genetics and Metabolism, conducted by a Liverpool based research collaboration involving the University of Liverpool, has identified the drug that treats the extremely rare genetic disease ...
Aug 1, 2018
The perception of PrEP as an excuse for promiscuity
In 2012, the FDA approved the use of the drug emtricitabine/tenofovir disoproxil fumarate ('Truvada') as an HIV Pre-exposure Prophylaxis (PrEP) to reduce the risk of HIV infection in the event of exposure. Taking daily PrEP ...
Aug 1, 2018